2_SAGE_Appendicies_Background_final

More documents

Recommendations

Info

associated with particular ethnic minorities (ethnic Hmong) and remotecommunities, with a particular focus on the education level of the localpopulation in remote communities. Vaccine hesitancy is associated with lack ofperceived benefits of immunization and negative beliefs based on myths (such asvaccination of women leading to infertility).• % of un- or under-vaccinated in whom lack of confidence was afactor: 30% (estimated, % of Hmong tribe population)Country KVaccine hesitancy exists in the country, but is rather small. Vaccine hesitancy ismostly associated with people of high socio-economic status living in urban areaswho have concerns regarding vaccine safety (especially thiomersal containingvaccines). Concerns regarding porcine components in vaccines by Muslimpopulations also contribute to vaccine hesitancy in the country.• % of un- or under-vaccinated in whom lack of confidence was afactor:
Figure 1. IMs’ opinions regarding determinants of Vaccine Hesitancy*<strong>SAGE</strong> WG Vaccine Hesitancy ModelCONTEXTUALINFLUENCESINDIVIDUAL ANDGROUPINFLUENCESVACCINE ANDVACCINATIONSPECIFIC ISSUESReligion/ culture/gender/ socioeconomicInfluential leaders andanti- or pro-vaccinationlobbiesCommunication andmedia environmentGeographic barriersPolitics/ policies (Mandates)Historical influencesPharmaceutical industryRisk/ benefit(perceived, heuristic)Health system andproviders - trust andpersonal experienceKnowledge/ awarenessExperience with past vaccinationBeliefs, attitudes about health andpreventionImmunisation as a social norm vs.not needed/ harmfulRisk/ Benefit(scientific evidence)Design of vaccinationprogram/ Mode ofdeliveryReliability and/or sourceof vaccine supplyIntroduction of a newvaccine or new formulation*Larger font size represents greater number of mentions while determinants under the line were not mentioned by the IMs.CostsVaccination scheduleMode of administrationRole of healthcare professionals22
Page 1: APPENDICES TO THEREPORT OF THE SAGE
Page 4 and 5: vaccine hesitancy in low income cou
Page 6 and 7: INDIVIDUAL andGROUPINFLUENCESInflue
Page 8 and 9: Another model reviewed by the Worki
Page 10 and 11: Appendix for Section 4Appendix A4.1
Page 13 and 14: epresented mostly low and middle in
Page 15 and 16: was more hesitant than the younger
Page 17 and 18: a variable or to a lack of understa
Page 19 and 20: References[1] World Health Organiza
Page 21: Country FVaccine hesitancy is not a
Page 25 and 26: DefinitionVaccination confidence is
Page 27 and 28: Of all participating countries, 19%
Page 29 and 30: Countries from all 3 regions provid
Page 31 and 32: Table 5: Income level of countries
Page 33 and 34: variety of determinants of vaccine
Page 35 and 36: Uruguay no no responseVenezuela no
Page 37 and 38: RussianFederationyesQuestioning dur
Page 39 and 40: Question 2:Was this % measured or e
Page 41 and 42: Of those countries which submitted
Page 43 and 44: Indicator 2:Indicator 2 was modifie
Page 45 and 46: Table 4. Top three reasons for vacc
Page 47 and 48: The overall response rate to both i
Page 49 and 50: Czech Republic No 1. The fear of si
Page 51 and 52: Kyrgyzstan Yes В 2013 году в
Page 53 and 54: Table A5.3 .1: Survey questions to
Page 55 and 56: Table A5.3.1: Survey questions to a
Page 57 and 58: Table A5.3.2: Survey questions to a
Page 59 and 60: Appendix A5.4 WHO EUR Tailoring Imm
Page 61 and 62: Objective 2 - Characteristics of ev
Page 63 and 64: Most interventions targeted parents
Page 65 and 66: Table 2. PICO questions proposed by
Page 67 and 68: Dialogue-based interventionsEleven
Page 69 and 70: The impact of information-based tra
Page 71 and 72: Conclusions and implicationsLiterat
Page 73 and 74:
Appendix A6A.2 Strategies to addres
Page 75 and 76:
change in attitudes).- Most studies
Page 77 and 78:
Strategies to address vaccine hesit
Page 79 and 80:
Table 1.Summary of published litera
Page 81 and 82:
Title/ First author/year of publica
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
References1. Williams, S.E., What a
Page 93 and 94:
Appendix A6C.1 Vaccine Hesitancy La
Page 95 and 96:
ii. Google (Hong Kong)• Used the
Page 97 and 98:
Categories Key Actors Areas ofWork/
Page 99 and 100:
Page 101 and 102:
Categories Key Actors Areas ofActio
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
This landscape analysis, along with
Page 109 and 110:
References for Vaccine Hesitancy La
Page 111:
67 Robert Wood Johnson Foundation.
show all

2_SAGE_Appendicies_Background_final

Create successful ePaper yourself

Delete template?

Save as template?